| Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A X Xue, X Wang, Y Zhao, R Hu, L Qin Biochemical and biophysical research communications 502 (4), 515-521, 2018 | 103 | 2018 |
| miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer X Xue, X Fei, W Hou, Y Zhang, L Liu, R Hu Cancer letters 412, 170-178, 2018 | 97 | 2018 |
| Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability N Zeng, Q Hu, Z Liu, X Gao, R Hu, Q Song, G Gu, H Xia, L Yao, Z Pang, ... International journal of pharmaceutics 424 (1-2), 58-66, 2012 | 88 | 2012 |
| Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma X Xue, Y Zhao, X Wang, L Qin, R Hu Journal of cellular biochemistry 120 (1), 135-142, 2019 | 83 | 2019 |
| miR-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9 H Huang, Y Wang, Q Li, X Fei, H Ma, R Hu Cancer letters 446, 81-89, 2019 | 69 | 2019 |
| Quantitative secretomic analysis identifies extracellular protein factors that modulate the metastatic phenotype of non-small cell lung cancer R Hu, KE Huffman, M Chu, Y Zhang, JD Minna, Y Yu Journal of proteome research 15 (2), 477-486, 2016 | 59 | 2016 |
| Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells XD Wang, R Hu, Q Ding, TK Savage, KE Huffman, N Williams, MH Cobb, ... Nature communications 10 (1), 3201, 2019 | 38 | 2019 |
| Shizukaol D isolated from Chloranthus japonicas inhibits AMPK-dependent lipid content in hepatic cells by inducing mitochondrial dysfunction R Hu, H Yan, X Hao, H Liu, J Wu PloS one 8 (8), e73527, 2013 | 35 | 2013 |
| Modulation of glucose metabolism by a natural compound from Chloranthus japonicus via activation of AMP-activated protein kinase R Hu, H Yan, X Fei, H Liu, J Wu Scientific Reports 7 (1), 778, 2017 | 33 | 2017 |
| miR-137-3p modulates the progression of prostate cancer by regulating the JNK3/EZH2 axis Y Zang, J Zhu, Q Li, J Tu, X Li, R Hu, D Yang OncoTargets and therapy, 7921-7932, 2020 | 25 | 2020 |
| CpG oligodeoxynucleotide developed to activate primate immune responses promotes antitumoral effects in combination with a neoantigen-based mRNA cancer vaccine Q Li, J Ren, W Liu, G Jiang, R Hu Drug Design, Development and Therapy, 3953-3963, 2021 | 22 | 2021 |
| Dysregulation of SPRR3/miR-876-3p axis contributes to tumorigenesis in non-small-cell lung cancer Q Li, Y Wang, R Hu, G Yang OncoTargets and therapy, 2411-2419, 2020 | 22 | 2020 |
| Circulating HER‑2 mRNA in the peripheral blood as a potential diagnostic and prognostic biomarker in females with breast cancer Y Wu, Q Meng, Z Yang, L Shi, R Hu, P Zhang, J Wei, J Ren, B Leng, D Xu, ... Oncology Letters 16 (3), 3726-3734, 2018 | 12 | 2018 |
| Circular RNA hsa_circ_0001306 functions as a competing endogenous RNA to regulate FBXW7 expression by sponging miR-527 in hepatocellular carcinoma Y Wu, T Fan, Y Zhao, R Hu, D Yan, D Sun, L Gao, L Qin, X Xue Journal of Cancer 12 (21), 6531, 2021 | 7 | 2021 |
| Surgical excision and oncoplastic breast surgery in 32 patients with benign phyllodes tumors J Ren, L Jin, B Leng, R Hu, G Jiang World Journal of Surgical Oncology 16, 1-4, 2018 | 7 | 2018 |
| Targeted LNPs deliver mRNA encoding IL-15 superagonists to balance efficacy and toxicity in cancer therapy J Yu, Q Li, S Luo, X Wang, Q Cheng, R Hu bioRxiv, 2024.01. 11.575299, 2024 | | 2024 |
